HR Execs on the Move

Esperion

www.esperion.com

 
Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren`t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. Esperion commercializes NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Tablets and is the leader in the development of convenient oral, once-daily non-statin LDL-cholesterol lowering drugs for patients with high levels of bad ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.esperion.com
  • 3891 Ranchero Drive Suite 150
    Ann Arbor, MI USA 48108
  • Phone: 734.887.3903

Executives

Name Title Contact Details
Lauren Hart
Associate Director, HCP Marketing Profile
Ben Halladay
Chief Financial Officer Profile
Stephen Pinkosky
Senior Director, R&D Profile
Andrew Bramble
Sr. Manager, Drug Product Technical Services Profile
Marianne Andreach
Senior Vice President, Product Planning Profile

Similar Companies

Owl

Better data. Better insights. Better outcomes for behavioral health.

Zitomer Pharmacy Inc

Zitomer Pharmacy Inc is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Board of Pain Medicine

American Board of Pain Medicine is a Glenview, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GL Sciences

GL Sciences is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Precision for Medicine

At Precision for Medicine, we help our pharmaceutical and life sciences clients innovate, develop, and commercialize next generation medical products. Backed by a diverse team of experts across the spectrum of the healthcare marketplace, we provide a comprehensive and integrated set of services that help accelerate research, enable market adoption, enhance patient outcomes, and realize the full commercial potential of new therapies and products.